Medicaid

Another reason to be glad HUSKY fired managed care

New favorite quote – “If you have a dumb incentive system, you get dumb outcomes.” Charlie Munger, quoted by 46brooklyn A new analysis by 46brooklyn highlights the extra costs to Medicaid managed care programs of drug industry middlemen. Ohio’s Medicaid program pays $224 extra in markups to Pharmacy Benefit Managers (PBMs) hired by managed care…

Read More

Medicaid update: Enrollment numbers coming finally, highlighting progress

Friday’s Medicaid Council meeting focused on enrollment numbers and reviewing achievements in the program. DSS outlined challenges that have delayed reporting enrollment numbers for two years and their new system for reporting the numbers. Rather than getting enrollment reports on paper as in the past, DSS is posting the data on CT Open Data. Visitors…

Read More

Connecticut’s uninsured rate up, reversing four-year trend

New numbers from the US Census Bureau report that 194,000 or 5.5% of Connecticut residents were uninsured last year. That number is up 22,000 from the year before when the uninsured rate was 4.9%. The new data breaks a trend of fewer uninsured that began with implementation of coverage expansions under the Affordable Care Act…

Read More

CT excels at getting Medicaid-eligible families enrolled

A new study finds that 96.3% of CT children eligible for HUSKY participated in the program in 2016; we are tied for seventh among states. The US average is 93.7% for all states; 94.9% for states, like CT, that expanded Medicaid under the Affordable Care Act. Even better, CT ranks fourth among states in enrolling…

Read More

Lidocaine patch leads CT Medicaid drug spending

According to the latest data visualization from 46brooklyn, CT’s Medicaid program is spending a lot on lidocaine patches. Lidocaine is a local anesthetic that relieves nerve pain. Over the last three available quarters (Q3,4 2017 and Q1 2018), Lidocaine patches have topped CT Medicaid’s list of 25 most costly medications. This medication isn’t on the…

Read More
Processing...
Thank you! Your subscription has been confirmed. You'll hear from us soon.
ErrorHere